Cytokinetics board of directors
WebCYTOKINETICS, INCORPORATED 2004 EQUITY INCENTIVE PLAN, AS AMENDED (As amended by the Board of Directors on February 6, 2013; Stockholder approval May 22, 2013; updated following reverse stock split June 25, 2013) from Cytokinetics, Incorporated filed with the Securities and Exchange Commission. WebFeb 12, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that Robert Califf, M.D., has been appointed to the company’s Board of Directors. Dr. Califf is the Vice Chancellor for Health Data Science at Duke Health and Director of the Duke University Center for …
Cytokinetics board of directors
Did you know?
WebNumbers reported do not include change in pension value and non-qualified deferred compensation earnings. CEO Pay Ratio For its 2024 fiscal year, CYTOKINETICS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC. Browse Board of Directors By First Name A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
WebHansel works extremely smart, building strong relationships, built upon strong scientific knowledge and preparation. Hansel is a savvy … WebNov 18, 2024 · Cytokinetics Board Members Name & TitleBio Robert I. Blum CEO / President Robert was appointed President and Chief Executive Officer of Cytokinetics in January 2007 and has been a member of our Board of Directors since then.
WebCYTOKINETICS, INCORPORATED 2004 EQUITY INCENTIVE PLAN, AS AMENDED (As amended by the Board of Directors on February 6, 2013; Stockholder approval May 22, … WebBoard of Directors Scientific Advisory Board Robert I. Blum President And Chief Executive Officer Andrew Callos EVP, Chief Commercial Officer Daniel R. Casper VP, Information Technology Bonnie A. Charpentier, Ph.D. SVP, Regulatory Affairs and Compliance … Vision 2024: Empowering Our Future. Vision 2025. Vision 2025: “Leading with … Robert has served as our President and Chief Executive Officer of Cytokinetics … Cytokinetics is a late-stage biopharmaceutical company focused on …
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. ... Dr. Harrington has served as a member of our Board of Directors since April 2024. He is a cardiologist and the Arthur L. Bloomfield Professor of Medicine and Chair of the Department of Medicine …
WebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced changes to its Board of … inconsistency\u0027s ebWebBoard Of Directors, Chair of Marketing and Communications Committee ... Cytokinetics’ experimental drug aficamten looks like it will be another good option for patients. More tools are… incident in purley todayWebWe are pleased to welcome Dr. Robert Harrington to our Board of Directors. He brings years of expertise and experience as a practicing cardiologist, professor… incident in preston road wembley todayWeb“Incumbent Directors” means directors who either (A) are Directors as of the effective date of the Plan, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or ... incident in potters bar todayWebFeb 18, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 18, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Muna Bhanji has … inconsistency\u0027s elWebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced changes to its Board of Directors. L. Patrick Gage, Ph.D., Chairman of the Board of Directors since March 2010, will resign from the Board effective April 8, 2024. incident in putney todayWebFeb 20, 2009 · Dr. Henderson joins the Cytokinetics Board of Directors with over 30 years of experience in the life science industry. Since December 2000, Dr. Henderson has served as a consultant to the pharmaceutical industry as president of Futurepharm LLC. Until his retirement in December 2000, Dr. Henderson was an employee of Pfizer Inc. for over 25 … incident in pudsey today